DMD cardiomyocytes showed Ca2+ handling abnormalities including increased release and reuptake times, in addition to impaired localization of RYR2s, all of which were corrected with the truncated dystrophin lines. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.